United Therapeutics is a biotechnology company that develops and markets therapies for pulmonary arterial hypertension and other rare diseases, and is pursuing organ-manufacturing and xenotransplantation.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | Added +18% | 201,159 | $108,993,981 | 0.1% |
| Bridgewater | 56 | Holds (flat) | 111,326 | $60,319,767 | 0.2% |
| Ancora | 40 | Holds (flat) | 10 | $5,418 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -59% | 12,667 | $6,863,361 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-08-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.